The IgA antibody levels in tear fluid samples were not significantly affected by the disease stage (Figure 4) or the application of specialized treatments such as oxygen therapy or ICU treatment in response to multiple organ failure. This evidence concerns the gene CD79A and Multiple Organ Failure.